carisoprodol

Generic: carisoprodol

Labeler: westminster pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name carisoprodol
Generic Name carisoprodol
Labeler westminster pharmaceuticals, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

carisoprodol 350 mg/1

Manufacturer
Westminster Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 69367-420
Product ID 69367-420_32737384-3aa8-40d2-8e2b-5b08efbdbcfc
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA207237
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2025-11-25

Pharmacologic Class

Established (EPC)
muscle relaxant [epc]
Physiologic Effect
centrally-mediated muscle relaxation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69367420
Hyphenated Format 69367-420

Supplemental Identifiers

RxCUI
197446 730794
UPC
0369367419017 0369367420013
UNII
21925K482H
NUI
N0000175730 N0000175737

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name carisoprodol (source: ndc)
Generic Name carisoprodol (source: ndc)
Application Number ANDA207237 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 350 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (69367-420-01)
  • 500 TABLET in 1 BOTTLE (69367-420-05)
source: ndc

Packages (2)

69367-420-01 100 TABLET in 1 BOTTLE (69367-420-01) 69367-420-05 500 TABLET in 1 BOTTLE (69367-420-05)

Ingredients (1)

carisoprodol (350 mg/1)

Linked Drug Pages (1)

Carisoprodol ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "32737384-3aa8-40d2-8e2b-5b08efbdbcfc", "openfda": {"nui": ["N0000175730", "N0000175737"], "upc": ["0369367419017", "0369367420013"], "unii": ["21925K482H"], "rxcui": ["197446", "730794"], "spl_set_id": ["bfb31551-8c57-4360-be3a-f6fbe84a891e"], "pharm_class_pe": ["Centrally-mediated Muscle Relaxation [PE]"], "pharm_class_epc": ["Muscle Relaxant [EPC]"], "manufacturer_name": ["Westminster Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (69367-420-01)", "package_ndc": "69367-420-01", "marketing_start_date": "20251125"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (69367-420-05)", "package_ndc": "69367-420-05", "marketing_start_date": "20251125"}], "brand_name": "Carisoprodol", "product_id": "69367-420_32737384-3aa8-40d2-8e2b-5b08efbdbcfc", "dosage_form": "TABLET", "pharm_class": ["Centrally-mediated Muscle Relaxation [PE]", "Muscle Relaxant [EPC]"], "product_ndc": "69367-420", "dea_schedule": "CIV", "generic_name": "Carisoprodol", "labeler_name": "Westminster Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Carisoprodol", "active_ingredients": [{"name": "CARISOPRODOL", "strength": "350 mg/1"}], "application_number": "ANDA207237", "marketing_category": "ANDA", "marketing_start_date": "20251125", "listing_expiration_date": "20261231"}